XML 31 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2012
SEGMENT INFORMATION  
Financial information regarding the Company's reportable segments

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2012

 

2011

 

2012

 

2011

 

 

 

 

 

 

 

 

 

 

 

Total Revenue:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

362,077

 

$

391,535

 

$

1,115,766

 

$

1,178,065

 

Pharma

 

156,044

 

146,521

 

429,278

 

417,793

 

Food + Beverage

 

75,245

 

68,101

 

226,751

 

211,350

 

Corporate & Other

 

 

40

 

 

122

 

Total Revenue

 

593,366

 

606,197

 

1,771,795

 

1,807,330

 

 

 

 

 

 

 

 

 

 

 

Less: Intersegment Sales:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

3,601

 

$

4,034

 

$

10,855

 

$

11,564

 

Pharma

 

(56

)

76

 

156

 

641

 

Food + Beverage

 

223

 

851

 

1,185

 

2,360

 

Corporate & Other

 

 

40

 

 

122

 

Total Intersegment Sales

 

$

3,768

 

$

5,001

 

$

12,196

 

$

14,687

 

 

 

 

 

 

 

 

 

 

 

Net Sales:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

358,476

 

$

387,501

 

$

1,104,911

 

$

1,166,501

 

Pharma

 

156,100

 

146,445

 

429,122

 

417,152

 

Food + Beverage

 

75,022

 

67,250

 

225,566

 

208,990

 

Corporate & Other

 

 

 

 

 

Net Sales

 

$

589,598

 

$

601,196

 

$

1,759,599

 

$

1,792,643

 

 

 

 

 

 

 

 

 

 

 

Segment Income:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

30,050

 

$

32,025

 

$

96,674

 

$

104,555

 

Pharma

 

34,194

 

44,801

 

104,676

 

124,058

 

Food + Beverage

 

9,611

 

6,891

 

24,252

 

23,076

 

Corporate  & Other

 

(6,443

)

(9,964

)

(22,048

)

(28,634

)

Income before interest and taxes

 

$

67,412

 

$

73,753

 

$

203,554

 

$

223,055

 

Interest expense, net

 

(4,386

)

(2,515

)

(11,710

)

(8,646

)

Income before income taxes

 

$

63,026

 

$

71,238

 

$

191,844

 

$

214,409